Association of clinical trial participation after myocardial infarction with socioeconomic status, clinical characteristics, and outcomes.

Clinical trial participants post-MI are more often male, have higher SES, a more advantageous risk profile, and better prognosis. Additional unmeasured participation bias was implied. Questionable external validity of post-MI trials highlights the importance of complementary studies using real-world data.